BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 30922625)

  • 1. IL-6 promotes endometrial cancer cells invasion and migration through signal transducers and activators of transcription 3 signaling pathway.
    Che Q; Xiao X; Liu M; Lu Y; Dong X; Liu S
    Pathol Res Pract; 2019 Jun; 215(6):152392. PubMed ID: 30922625
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Paracrine IL-6 signaling mediates the effects of pancreatic stellate cells on epithelial-mesenchymal transition via Stat3/Nrf2 pathway in pancreatic cancer cells.
    Wu YS; Chung I; Wong WF; Masamune A; Sim MS; Looi CY
    Biochim Biophys Acta Gen Subj; 2017 Feb; 1861(2):296-306. PubMed ID: 27750041
    [TBL] [Abstract][Full Text] [Related]  

  • 3. OGT regulated O-GlcNacylation promotes migration and invasion by activating IL-6/STAT3 signaling in NSCLC cells.
    Ge X; Peng X; Li M; Ji F; Chen J; Zhang D
    Pathol Res Pract; 2021 Sep; 225():153580. PubMed ID: 34391182
    [TBL] [Abstract][Full Text] [Related]  

  • 4. STAT3 activation by IL-6 from adipose-derived stem cells promotes endometrial carcinoma proliferation and metastasis.
    Chu Y; Wang Y; Peng W; Xu L; Liu M; Li J; Hu X; Li Y; Zuo J; Ye Y
    Biochem Biophys Res Commun; 2018 Jun; 500(3):626-631. PubMed ID: 29684351
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Acrp30 inhibits leptin-induced metastasis by downregulating the JAK/STAT3 pathway via AMPK activation in aggressive SPEC-2 endometrial cancer cells.
    Wu X; Yan Q; Zhang Z; Du G; Wan X
    Oncol Rep; 2012 May; 27(5):1488-96. PubMed ID: 22327423
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Gankyrin promotes tumor growth and metastasis through activation of IL-6/STAT3 signaling in human cholangiocarcinoma.
    Zheng T; Hong X; Wang J; Pei T; Liang Y; Yin D; Song R; Song X; Lu Z; Qi S; Liu J; Sun B; Xie C; Pan S; Li Y; Luo X; Li S; Fang X; Bhatta N; Jiang H; Liu L
    Hepatology; 2014 Mar; 59(3):935-46. PubMed ID: 24037855
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Interleukin 11 regulates endometrial cancer cell adhesion and migration via STAT3.
    Lay V; Yap J; Sonderegger S; Dimitriadis E
    Int J Oncol; 2012 Aug; 41(2):759-64. PubMed ID: 22614117
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Secretory RAB GTPase 3C modulates IL6-STAT3 pathway to promote colon cancer metastasis and is associated with poor prognosis.
    Chang YC; Su CY; Chen MH; Chen WS; Chen CL; Hsiao M
    Mol Cancer; 2017 Aug; 16(1):135. PubMed ID: 28784136
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Loss of SH3GL2 promotes the migration and invasion behaviours of glioblastoma cells through activating the STAT3/MMP2 signalling.
    Zhu Y; Zhang X; Wang L; Ji Z; Xie M; Zhou X; Liu Z; Shi H; Yu R
    J Cell Mol Med; 2017 Nov; 21(11):2685-2694. PubMed ID: 28470949
    [TBL] [Abstract][Full Text] [Related]  

  • 10. JAK/STAT3 signaling is required for TGF-β-induced epithelial-mesenchymal transition in lung cancer cells.
    Liu RY; Zeng Y; Lei Z; Wang L; Yang H; Liu Z; Zhao J; Zhang HT
    Int J Oncol; 2014 May; 44(5):1643-51. PubMed ID: 24573038
    [TBL] [Abstract][Full Text] [Related]  

  • 11. miR-124 functions as a tumor suppressor in the endometrial carcinoma cell line HEC-1B partly by suppressing STAT3.
    Li Y; Zhang Z; Liu X; Huang T; He W; Shen Y; Liu X; Hong K; Cao Q
    Mol Cell Biochem; 2014 Mar; 388(1-2):219-31. PubMed ID: 24287565
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Interleukin-23 promotes the migration and invasion of gastric cancer cells by inducing epithelial-to-mesenchymal transition via the STAT3 pathway.
    Xu X; Yang C; Chen J; Liu J; Li P; Shi Y; Yu P
    Biochem Biophys Res Commun; 2018 May; 499(2):273-278. PubMed ID: 29574157
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Targeting Interleukin-11 Receptor-α Impairs Human Endometrial Cancer Cell Proliferation and Invasion In Vitro and Reduces Tumor Growth and Metastasis In Vivo.
    Winship AL; Van Sinderen M; Donoghue J; Rainczuk K; Dimitriadis E
    Mol Cancer Ther; 2016 Apr; 15(4):720-30. PubMed ID: 26846819
    [TBL] [Abstract][Full Text] [Related]  

  • 14. STAT3 activation by IL-6 from mesenchymal stem cells promotes the proliferation and metastasis of osteosarcoma.
    Tu B; Du L; Fan QM; Tang Z; Tang TT
    Cancer Lett; 2012 Dec; 325(1):80-8. PubMed ID: 22743617
    [TBL] [Abstract][Full Text] [Related]  

  • 15. IL6-induced metastasis modulators p-STAT3, MMP-2 and MMP-9 are targets of 3,3'-diindolylmethane in ovarian cancer cells.
    Zou M; Zhang X; Xu C
    Cell Oncol (Dordr); 2016 Feb; 39(1):47-57. PubMed ID: 26510945
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Interleukin-6 promotes the migration and invasion of nasopharyngeal carcinoma cell lines and upregulates the expression of MMP-2 and MMP-9.
    Sun W; Liu DB; Li WW; Zhang LL; Long GX; Wang JF; Mei Q; Hu GQ
    Int J Oncol; 2014 May; 44(5):1551-60. PubMed ID: 24603891
    [TBL] [Abstract][Full Text] [Related]  

  • 17. PMA treated THP-1-derived-IL-6 promotes EMT of SW48 through STAT3/ERK-dependent activation of Wnt/β-catenin signaling pathway.
    Gao S; Hu J; Wu X; Liang Z
    Biomed Pharmacother; 2018 Dec; 108():618-624. PubMed ID: 30243096
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Minocycline suppresses interleukine-6, its receptor system and signaling pathways and impairs migration, invasion and adhesion capacity of ovarian cancer cells: in vitro and in vivo studies.
    Ataie-Kachoie P; Morris DL; Pourgholami MH
    PLoS One; 2013; 8(4):e60817. PubMed ID: 23593315
    [TBL] [Abstract][Full Text] [Related]  

  • 19. WSTF promotes proliferation and invasion of lung cancer cells by inducing EMT via PI3K/Akt and IL-6/STAT3 signaling pathways.
    Meng J; Zhang XT; Liu XL; Fan L; Li C; Sun Y; Liang XH; Wang JB; Mei QB; Zhang F; Zhang T
    Cell Signal; 2016 Nov; 28(11):1673-82. PubMed ID: 27449264
    [TBL] [Abstract][Full Text] [Related]  

  • 20. IL-6 secreted by cancer-associated fibroblasts promotes epithelial-mesenchymal transition and metastasis of gastric cancer via JAK2/STAT3 signaling pathway.
    Wu X; Tao P; Zhou Q; Li J; Yu Z; Wang X; Li J; Li C; Yan M; Zhu Z; Liu B; Su L
    Oncotarget; 2017 Mar; 8(13):20741-20750. PubMed ID: 28186964
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.